duloxetine hydrochloride has been researched along with pregabalin in 158 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (10.76) | 29.6817 |
| 2010's | 101 (63.92) | 24.3611 |
| 2020's | 40 (25.32) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Terneus, W | 1 |
| Wallace, JM | 1 |
| Kempler, P; Várkonyi, T | 1 |
| Baglioni, P; Govindan, J; Khan, A | 1 |
| Armstrong, DG; Wrobel, JS; Wu, SC | 1 |
| Robinson-Papp, J; Simpson, DM | 1 |
| Price, DD; Staud, R | 1 |
| Han, C; Marks, DC; Masand, PS; Pae, CU; Patkar, AA | 1 |
| Forde, G; Stanos, S | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
| Genth, E; Harten, P | 1 |
| Holloway, RG; Noyes, K; O'Connor, AB | 1 |
| Sipkoff, M | 1 |
| Chancellor, J; Garcia-Cebrian, A; Le, TK; Löthgren, M; Monz, B; Quilici, S; Said, G; Simon, D | 1 |
| Alda, M; Andrés, E; del Hoyo, YL; García-Campayo, J; Luciano, JV; Magallón, R; Rodero, B; Serrano-Blanco, A | 1 |
| Apostolaki, S; Arvaniti, C; Chatzimichael, K; Kitsiou, MC; Kostopanagiotou, G; Matsota, P | 1 |
| Rao, SG | 1 |
| Aliaga, M; Bardin, L; Depoortère, R; Gregoire, S; Ladure, P; Malfetes, N; Newman-Tancredi, A; Vitton, O | 1 |
| Staud, R | 1 |
| Briley, M | 1 |
| Kempler, P | 1 |
| Esfahani, F; Gomori, A; Grossberndt, A; Intrater, H; Klowak, M; Leong, C; Namaka, M; Turcotte, D | 1 |
| Bowrin, K; Choy, E; Lloyd, A; Richards, S; Sadosky, A; Watson, P; Zlateva, G | 1 |
| Häuser, W; Petzke, F; Sommer, C | 1 |
| Hettinger, K; Lindsay, TJ; Rodgers, BC; Savath, V | 1 |
| Cao, Z; Fowler, R; Harnett, J; Mardekian, J; Margolis, J; Sanchez, RJ; Silverman, SL | 1 |
| Budhia, S; Gabriel, Z; Plested, M | 1 |
| Sun, P; Watson, P; Zhao, Y | 1 |
| Armstrong, EP; Malone, DC; McCarberg, B; Panarites, CJ; Pham, SV | 1 |
| Burke, JP; Cappelleri, JC; Halpern, R; Joshi, AV; Kulakodlu, M; Sanchez, RJ | 2 |
| Barohn, RJ; Dimachkie, MM; Herbelin, L; Khan, S; McVey, A; Mittal, M; Mummaneni, RB; Pasnoor, M; Ridings, L; Saperstein, D; Wang, Y | 1 |
| Fleming, KF; Wu, JJ | 1 |
| Thiessen, CN; Traynor, AP; Traynor, LM | 1 |
| Ahl, J; Irving, GA; Malcolm, SK; Risser, RC; Robinson, MJ; Skljarevski, V; Tanenberg, RJ | 1 |
| Sun, P; Watson, P; Zhao, Y; Zhao, Z | 1 |
| Arora, V; Chopra, K; Kuhad, A | 1 |
| Chandran, A; Gore, M; Leslie, D; Tai, KS; Zlateva, G | 1 |
| Kruger, TH; Philippsohn, S | 1 |
| Carlos, F; Dueñas, H; Galindo-Suárez, RM; Ramírez-Gámez, J; Ramos, E | 1 |
| Rizzi, M; Sarzi-Puttini, P; Spaeth, M | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
| Bernauer, M; Sun, P; Watson, P; Zhao, Y; Zhao, Z | 1 |
| Miyazaki, R; Yamamoto, T | 1 |
| Banno, K; Inoue, N; Ito, S; Kotera, T; Kyoi, T; Nakamura, A; Nogawa, M; Sasagawa, T; Tajima, K; Takahashi, Y; Ueda, M; Yamashita, Y | 1 |
| Bellows, BK; Biskupiak, J; Dahal, A; Jiao, T | 1 |
| Fujisaka, Y; Kaneda, H; Koyama, A; Makimura, C; Matsuoka, H; Nakagawa, K; Okamoto, W; Otsuka, M; Tsurutani, J | 1 |
| Alten, R; Bär, KJ; Häuser, W; Petzke, F; Sommer, C; Späth, M; Tölle, T; Uçeyler, N; Winkelmann, A; Winter, E | 1 |
| Boyle, J; Coppini, DV; Eriksson, ME; Gouni, R; Gribble, L; Johnsen, S; Kerr, D | 1 |
| Iida, H; Matsumoto, S; Miyamoto, M; Takenaka, M; Yamaguchi, S; Yoshimura, N | 1 |
| Angeletti, C; Angeletti, PM; Ciccozzi, A; Guetti, C; Marinangeli, F; Paladini, A; Piroli, A; Varrassi, G | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Andrews, JS; Faries, DE; Novick, D; Peng, X; Sun, P; Sun, S; Wohlreich, MM; Wu, A | 1 |
| Amital, D; Amital, H; Arnson, Y; Milstein, R | 1 |
| Silvestri, NJ; Trivedi, JR; Wolfe, GI | 1 |
| Bouhassira, D; Cruccu, G; Freynhagen, R; Lledo, A; Schacht, A; Skljarevski, V; Tesfaye, S; Tölle, T; Wilhelm, S | 1 |
| Finnerup, NB | 1 |
| Kim, SC; Landon, JE; Solomon, DH | 1 |
| Boulton, AJ; Dickenson, AH; Tesfaye, S | 1 |
| Gupta, R; Koo, JY; Levin, E; Liao, W; Wu, JJ | 1 |
| Clemow, DB; Giaconia, JM; Risser, RC; Tanenberg, RJ | 1 |
| Cappelleri, JC; Chu, BC; Johnson, BH; Johnston, SS; Shrady, G; Silverman, SL; Udall, M | 2 |
| Birklein, F; Boess, FG; Happich, M; Schacht, A; Schneider, E; Wilhelm, S; Ziegler, D | 1 |
| Scheinfeld, N | 1 |
| Aldington, DJ; Kalso, E; Moore, RA | 1 |
| Aguado, J; Alda, M; Garcia-Campayo, J; Gili, M; Guallar, JA; López-Del-Hoyo, Y; Luciano, JV; Magallón, R; Olivan, B; Serrano-Blanco, A | 1 |
| Benoliel, R; Haviv, Y; Sharav, Y; Zadik, Y | 1 |
| Castagné, V; Le Cudennec, C | 1 |
| Callaghan, BC; Goutman, SA; Peltier, A | 1 |
| Huelin, R; Khankhel, Z; Mould, J; Parker, L; Wasiak, R | 1 |
| Irving, G; Malcolm, S; Raskin, J; Risser, RC; Tanenberg, RJ | 1 |
| Bouhassira, D; Choy, E; Cruccu, G; Freynhagen, R; Kosek, E; Lledó, A; Marchettini, P; Micó, JA; Perrot, S; Schacht, A; Skljarevski, V; Spaeth, M; Tesfaye, S; Tölle, T; Wilhelm, S | 1 |
| Cerdà-Lafont, M; Cuesta-Vargas, AI; D'Amico, F; García-Campayo, J; Knapp, M; Luciano, JV; Peñarrubia-María, MT; Serrano-Blanco, A | 1 |
| Cappelleri, JC; Clair, AG; Cook, JP; Eisenberg, DF; Gu, T; Masters, ET; Placzek, HE; Wasser, TE | 1 |
| Kim, SC; Landon, JE; Lee, YC | 1 |
| Cappelleri, JC; Ellis, JJ; Mudumby, P; Ndehi, L; Parsons, B; Sadosky, AB; Suehs, BT; Ten Eyck, LL | 1 |
| Liu, Y; Qian, C; Yang, M | 1 |
| Bouhassira, D; Choy, E; Cruccu, G; Freynhagen, R; Kosek, E; Lenox-Smith, A; Lledó, A; Marchettini, P; Micó, JA; Perrot, S; Petto, H; Skljarevski, V; Späth, M; Tesfaye, S; Tölle, T; Wilhelm, S | 1 |
| Egashira, N; Higuchi, H; Kaname, T; Kawashiri, T; Shirahama, M; Tsutsumi, K; Ushio, S; Yamamoto, S | 1 |
| Bellows, BK; LaFleur, J; Nelson, RE; Oderda, GM | 1 |
| Kiss, G | 1 |
| Carlos, F; Espejel, L; Flores, D; López, R; Novick, D | 1 |
| Alghamdi, H; Anwer, MM; Eliav, E; Khan, J; Ziccardi, V | 1 |
| Chaparro, LE; DuMerton-Shore, D; Gilron, I; Holden, RR; Milev, R; Towheed, T; Tu, D; Walker, S | 1 |
| Lee, YH; Song, GG | 1 |
| Hong, SD; Hwang, SG; Kim, SY; Lee, JH; Lee, YB; Oh, SH; Park, HN; Rim, KS; Shin, JK; Song, JH | 1 |
| Mehta, AK; Tripathi, CD; Yadav, AM | 1 |
| Gibbs, LM; Lindsay, TJ; Snyder, MJ | 1 |
| Chen, CK; Chen, YC; Chu, HT; Tzeng, NS; Yeh, TC | 1 |
| Cherrier, C; Di Patrizio, P; Poucher, AC; Poucher, M | 1 |
| Micov, A; Pecikoza, U; Stepanović-Petrović, R; Tomić, M | 1 |
| Aguado, J; D'Amico, F; Feliu-Soler, A; García-Campayo, J; Knapp, M; Luciano, JV; McCracken, LM; Peñarrubia-María, MT; Serrano-Blanco, A | 1 |
| Jo, A; Marlow, NM; Short, EB; Simpson, KN; Vaughn, IA; Zoller, JS | 1 |
| Alten, R; Bär, KJ; Bernateck, M; Brückle, W; Friedel, E; Häuser, W; Henningsen, P; Petzke, F; Sommer, C; Tölle, T; Üçeyler, N; Winkelmann, A | 1 |
| Katz, P; Liedgens, H; Pegoraro, V | 1 |
| Jermendy, G; Kempler, P; Keresztes, K; Körei, A; Lengyel, C; Martos, T; Nyiraty, S; Putz, Z; Stirban, A; Várkonyi, T | 1 |
| Bernardy, K; Häuser, W; Klose, P; Welsch, P | 1 |
| Di Cesare Mannelli, L; Farina, C; Ghelardini, C; Maresca, M; Micheli, L; Scherz, MW | 1 |
| Ajimi, J; Masuda, R; Murata, T | 1 |
| Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ | 1 |
| Murai, N; Naito, M; Nakano, T; Ohmichi, M; Ohmichi, Y; Oshibuchi, H; Sato, J; Takeshita, N; Yasui, M | 1 |
| Häuser, W; Klose, P; Üçeyler, N; Walitt, B; Welsch, P | 1 |
| Funatsu, Y; Furutani, M; Kiso, T; Matsuda, R; Moriyama, A | 1 |
| Barrick, TR; Howe, FA; Russell, MD; Sofat, N | 1 |
| Allen, R; Burke, L; Dworkin, RH; Farrar, JT; Gewandter, JS; Gilron, I; Katz, NP; Markman, JD; Marshall, SF; Patel, KV; Resnick, M; Rice, ASC; Rowbotham, MC; Smith, SM; Turk, DC; Vanhove, GF; Wasan, AD; Zhang, S | 1 |
| Altiparmak, B; Gümüş Demirbilek, S; Güzel, Ç | 1 |
| Bae, K; Jang, CE; Jung, MS; Kim, JR; Kim, M; Lee, JS; Sohn, EH; Yoo, HS | 1 |
| Bortolami, O; Bowler, H; Bradburn, M; Cooper, C; Julious, S; Loban, A; Petrie, J; Selvarajah, D; Sutherland, K; Swaby, L; Tesfaye, S; White, D | 1 |
| Desai, R; Jo, A; Marlow, NM | 1 |
| Dorsey, SG; Griffioen, MA; O'Toole, RV; Renn, CL; Ziegler, ML | 1 |
| Fusco, ML; Gentile, S | 1 |
| Ariyoshi, K; Inoue, A; Kizawa, Y; Koyama, A; Matsuoka, H; Oyamada, S; Tagami, K | 1 |
| Awaga, Y; Hama, A; Hayashi, I; Magata, Y; Natsume, T; Ogawa, S; Okamoto, S; Shidahara, Y; Takamatsu, H; Yamoto, K | 1 |
| Bidari, A; Ghavidel-Parsa, B; Hassankhani, A; Hosseini, S; Moazen-Zadeh, E; Rahmani, S | 1 |
| Ariyoshi, K; Hasegawa, Y; Hasuo, H; Ishiki, H; Iwase, S; Kataoka, Y; Kawaguchi, T; Koyama, A; Matsuda, Y; Matsumoto, Y; Matsuoka, H; Miyaji, T; Morita, T; Ohtake, Y; Otani, H; Otsuka, M; Oyamada, S; Sakai, K; Sakuma, H; Satomi, E; Shinomiya, T; Tokoro, A; Tsukuura, H; Yamaguchi, T | 1 |
| Bautista, J; Brown, JS; Curtis, LH; Dworkin, RH; Gewandter, JS; Kleckner, AS; Kleckner, IR; Kolb, N; Marshall, JH; Mohile, SG; Mustian, KM | 1 |
| Dworkin, RH; Gewandter, JS; Mbowe, OB; McDermott, MP; Turk, DC | 1 |
| Charnigo, RJ; Havens, JR; Lofwall, MR; Sun, J; Vickers-Smith, R; Walsh, SL | 1 |
| Jha, S; Mazumder, A; Sahani, OP; Siddiqui, S; Verma, MK; Waghdhare, S | 1 |
| Alipour, A; Avan, R; Hendouei, N; Janbabaei, G; Salehifar, E; Tabrizi, N | 1 |
| de Assis, MR; Dos Santos Paiva, E; Helfenstein, M; Heymann, RE; Martinez, JE; Pollak, DF; Provenza, JR; Ranzolin, A; Rezende, MC; Ribeiro, LS; Souza, EJR | 1 |
| Gül, HL; Gül, ŞK; Tepetam, H | 1 |
| Asaki, T; Fujita, M; Kasai, E; Matsuo, M; Sakurai, Y; Tamano, R; Yoneda, S | 1 |
| Corradini, L; Imam, MZ; Kuo, A; Nicholson, JR; Smith, MT | 1 |
| Ahmed, A; Ahmed, M; Austin, S; Barboi, A; Barohn, RJ; Bazant, M; Biliciler, S; Brannagan, T; Bril, V; Brown, A; Burns, T; Cash, T; Dimachkie, MM; Gajewski, B; Hayat, G; Hehir, M; Heitzman, D; Herbelin, LL; Hussain, Y; Iyadurai, S; Jacoby, M; Jawdat, O; Karam, C; Kimminau, KS; Kissel, J; Kolb, N; Kushlaf, H; Kutz, C; Ladha, S; Lewis, R; Li, Y; Lou, JS; Mallonee, W; Memon, A; Mudaranthakam, DP; Pascuzzi, R; Pasnoor, M; Pulley, M; Quan, D; Ralph, J; Ramchandren, S; Salajegheh, K; Saperstein, D; Scelsa, S; Sharma, K; Smith, G; Stino, A; Swenson, A; Thaisetthawatkul, P; Tobon, A; Trivedi, J; Twydell, P; Verma, N; Vu, T; Walk, D; Wicklund, M; Wolfe, G; Wymer, J | 1 |
| Balayssac, D; Busserolles, J; Farsi, F; Guastella, V; Kerckhove, N; Merle, P; Pereira, B; Pezet, D; Selvy, M | 1 |
| Awtoniuk, M; Furgała-Wojas, A; Sałat, K; Sałat, R | 1 |
| Corradini, L; Kuo, A; Nicholson, JR; Smith, MT | 1 |
| Barros, CM; Boralli, VB; Costa, LH; Galdino, G; Kawano, T; Placido, RV; Podesta, MHMC; Rodrigues, RF; Santos, RS | 1 |
| Cernea, S; Raz, I | 1 |
| Bidari, A; Gharibpoor, F; Ghavidel-Parsa, B; Khosousi, MJ; Rahimi, A | 1 |
| Makino, J; Mitsuboshi, S; Neo, M; Nishihara, M; Suzuki, K; Yamada, T | 1 |
| Agar, M; Allcroft, P; Ariyoshi, K; Brown, L; Clark, K; Currow, DC; Fazekas, B; Fujiwara, N; Hasuo, H; Ishiki, H; Iwase, S; Kochovska, S; Koyama, A; Le, B; Lee, J; Lovell, M; Matsuda, Y; Matsuoka, H; Miyaji, T; Oyamada, S; Phillips, J; Satomi, E; Yamaguchi, T | 1 |
| Colarossi, G; Eschweiler, J; Knobe, M; Maffulli, N; Migliorini, F; Tingart, M | 1 |
| Asama, H; Hashimoto, M; Hikichi, T; Irie, H; Kato, T; Kobashi, R; Konno, N; Nakamura, J; Ohira, H; Okubo, Y; Sato, Y; Sugimoto, M; Suzuki, R; Takagi, T; Takasumi, M | 1 |
| Alberti, FF; Becker, MW; Blatt, CR; da Silva Dal Pizzol, T; Pilger, D; Ziegelmann, PK | 1 |
| Akpinar, P; Aktas, I; Atici, A; Begoglu, FA; Illeez, OG; Kaysin, MY; Nazligül, T; Oktay, KNK; Ozkan, FU | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Barohn, RJ; Bhai, SF; Brown, A; Gajewski, B; Kimminau, KS; Pasnoor, M; Waitman, LR | 1 |
| Doucette, JA; Eguale, T; Farag, HM; Goswami, H; Sultan, I; Yunusa, I | 1 |
| Cooper, JM; Isbister, GK; Isoardi, KZ; Keegan, M; Polanski, R | 1 |
| Davis, M; Loprinzi, C | 1 |
| Ahmed, SH; Alam, U; Bennett, DL; Bouhassira, D; Bradburn, M; Cooper, C; Devers, M; Gandhi, R; Glover, R; Gouni, R; Hariman, C; Horspool, M; Johnson, M; Jude, EB; Julious, S; Loban, A; Maguire, D; McDougall, C; Petrie, J; Rajbhandari, S; Rayman, G; Rice, ASC; Selvarajah, D; Sharma, S; Sloan, G; Sutherland, K; Tesfaye, S; Tsatlidis, V; Turton, E; Vas, P; Waterhouse, S; White, D | 1 |
| Blalock, M; Chin, JJ; Nguyen, J | 1 |
| Capon, C; Crevant, A; Moreau, N; Pointin, A; Sulukdjian, A | 1 |
| Benoliel, R; Eliav, E; Khan, J; Korczeniewska, OA; McNeil, R; Ren, Y; Wang, Q | 1 |
| Chen, KY; Li, RY | 1 |
| Aster, HC; Braun, A; Evdokimov, D; Sommer, C; Üçeyler, N | 1 |
| Ahmed, SH; Alam, U; Bennett, DL; Bouhassira, D; Bradburn, M; Cooper, C; Devers, M; Gandhi, R; Glover, R; Gouni, R; Hariman, C; Horspool, M; Johnson, M; Jude, E; Julious, SA; Loban, A; Maguire, D; McDougall, C; Petrie, J; Rajbhandari, S; Rayman, G; Selvarajah, D; Sharma, S; Sloan, G; Sutherland, K; Tesfaye, S; Tsatlidis, V; Turton, E; Vas, P; Waterhouse, S; White, D; Young, T | 1 |
| Dang, L; Vandal, C; Winslow, BT | 1 |
| Nodera, H | 1 |
| Barry, HC | 1 |
| Deeney, B; Imison, C; Saul, H; Tesfaye, S | 1 |
| Baldwin, DS; Fagan, HA | 1 |
| Di Carlo, M; Farah, S; Salaffi, F; Sarzi-Puttini, P | 1 |
| Flynn, D | 1 |
41 review(s) available for duloxetine hydrochloride and pregabalin
| Article | Year |
|---|---|
Update on pharmacotherapy guidelines for treatment of neuropathic pain.
Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2007 |
Diabetic neuropathy: new strategies for treatment.
Topics: Aldehyde Reductase; Amines; Analgesics; Anticonvulsants; Antidepressive Agents; Antioxidants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Thiamine; Thioctic Acid; Thiophenes | 2008 |
Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia.
Topics: Antidepressive Agents; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic; Thiophenes | 2007 |
Safety profile of treatment in diabetic peripheral neuropathic pain.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanols; Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Thiophenes; Venlafaxine Hydrochloride | 2007 |
Practical management strategies for the chronic pain patient.
Topics: Administration, Cutaneous; Amines; Analgesics; Antidepressive Agents, Tricyclic; Carbamazepine; Chronic Disease; Clinical Protocols; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Monitoring; Drug Tolerance; Duloxetine Hydrochloride; Family Practice; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Middle Aged; Pain; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Substance-Related Disorders; Thiophenes; Treatment Outcome | 2007 |
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
Topics: Amines; Analgesics; Analysis of Variance; Bayes Theorem; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pain Measurement; Peripheral Nervous System; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2009 |
Current progress in the pharmacological therapy of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Animals; Clinical Trials as Topic; Cyclopropanes; Drugs, Investigational; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2009 |
A treatment algorithm for neuropathic pain: an update.
Topics: Algorithms; Analgesics; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain Measurement; Paroxetine; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2009 |
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Topics: Analgesics; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2010 |
Treating diabetic peripheral neuropathic pain.
Topics: Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Complementary Therapies; Diabetic Neuropathies; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pain Measurement; Pregabalin; Recovery of Function; Thiophenes | 2010 |
Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.
Topics: Analgesics; Anesthetics, Local; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Lidocaine; Neuralgia; Pregabalin; Thiophenes; Treatment Outcome | 2010 |
Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Topics: Administration, Topical; Amines; Anesthetics, Local; Antidepressive Agents, Tricyclic; Capsaicin; Clinical Trials as Topic; Costs and Cost Analysis; Cyclohexanecarboxylic Acids; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Male; Markov Chains; Neuralgia, Postherpetic; Pregabalin; Quality of Life; Sensory System Agents; Thiophenes; Transdermal Patch | 2011 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Thiophenes | 2011 |
Neoteric pharmacotherapeutic targets in fibromyalgia.
Topics: Animals; Cyclopropanes; Drug Approval; Drug Delivery Systems; Drug Design; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Thiophenes; United States; United States Food and Drug Administration | 2011 |
Fibromyalgia and sleep.
Topics: Analgesics; Central Nervous System Sensitization; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Physical Therapy Modalities; Polysomnography; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Syndrome; Thiophenes | 2011 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
Topics: Amitriptyline; Analgesics; Analgesics, Opioid; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Germany; Humans; Interdisciplinary Communication; Off-Label Use; Patient Care Team; Pregabalin; Somatoform Disorders; Thiophenes | 2012 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
Treatment of painful peripheral neuropathy.
Topics: Analgesics; Antidepressive Agents; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain Management; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2013 |
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.
Topics: Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2013 |
Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
Topics: Acetaminophen; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hidradenitis Suppurativa; Humans; Pain; Pain Management; Pregabalin; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Thiophenes; Venlafaxine Hydrochloride | 2013 |
Painful diabetic neuropathy.
Topics: Amines; Analgesics; Analgesics, Opioid; Biopsy; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypoglycemic Agents; Pregabalin; Sensory Thresholds; Skin; Thiophenes; Touch Perception | 2014 |
A systematic review of pharmacoeconomic studies for pregabalin.
Topics: Amines; Analgesics; Anticonvulsants; Chronic Disease; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Economics, Pharmaceutical; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Health Services; Humans; Neuralgia; Pregabalin; Quality of Life; Quality-Adjusted Life Years; Spain; Sweden; United States | 2015 |
[DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
Topics: Amines; Amitriptyline; Analgesics, Non-Narcotic; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia; Practice Guidelines as Topic; Pregabalin; Thiophenes | 2015 |
Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Topics: Analgesics; Cyclopropanes; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Network Meta-Analysis; Pregabalin; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Treating Painful Diabetic Peripheral Neuropathy: An Update.
Topics: Administration, Topical; Amines; Amitriptyline; Analgesics; Analgesics, Opioid; Anesthetics, Local; Capsaicin; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Isosorbide Dinitrate; Lidocaine; Phenols; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sensory System Agents; Serotonin and Noradrenaline Reuptake Inhibitors; Tapentadol; Tramadol; Transcutaneous Electric Nerve Stimulation; Vasodilator Agents; Venlafaxine Hydrochloride | 2016 |
[Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].
Topics: Amitriptyline; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; Fibromyalgia; Germany; Humans; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Societies, Medical | 2017 |
Advances in the management of diabetic neuropathy.
Topics: Adjuvants, Immunologic; Amines; Anticonvulsants; Antidepressive Agents; Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Randomized Controlled Trials as Topic; Thiamine; Thioctic Acid; Treatment Outcome | 2017 |
Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - A systematic review and meta-analysis of randomized controlled trials.
Topics: Adaptation, Psychological; Cognitive Behavioral Therapy; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain Management; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Pharmacotherapy for Neuropathic Pain in Japan.
Topics: Aged; Algorithms; Amines; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Japan; Neuralgia; Pain Management; Pregabalin | 2017 |
Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Topics: 5-Hydroxytryptophan; Acetaminophen; Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Benzodiazepines; Carisoprodol; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Fluoxetine; Humans; Magnesium; Malates; Melatonin; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Pregabalin; Randomized Controlled Trials as Topic | 2018 |
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Adult; Carnitine; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Norepinephrine; Pregabalin; Quality of Life; Selective Serotonin Reuptake Inhibitors; Syndrome | 2018 |
Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU.
Topics: Anti-Anxiety Agents; Duloxetine Hydrochloride; Europe; Female; Fibromyalgia; Humans; Milnacipran; Pregabalin; Pregnancy; Pregnancy Complications; Risk Assessment; Serotonin and Noradrenaline Reuptake Inhibitors; United States | 2019 |
Management of diabetic neuropathy.
Topics: Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; Humans; Life Style; Pain Management; Pregabalin; Risk Factors; Weight Loss | 2021 |
Pharmacological management of fibromyalgia: a Bayesian network meta-analysis.
Topics: Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Gabapentin; Humans; Network Meta-Analysis; Pregabalin | 2022 |
Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Peripheral Nervous System Diseases; Pregabalin; Randomized Controlled Trials as Topic | 2022 |
Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.
Topics: Adolescent; Adult; Amitriptyline; Child; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Network Meta-Analysis; Pain; Pregabalin; Randomized Controlled Trials as Topic | 2022 |
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.
Topics: Amitriptyline; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Network Meta-Analysis; Pain; Pregabalin; United States; United States Food and Drug Administration | 2022 |
Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Treatment Outcome | 2022 |
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins | 2022 |
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Duloxetine Hydrochloride; Humans; Pregabalin; Treatment Outcome | 2023 |
30 trial(s) available for duloxetine hydrochloride and pregabalin
| Article | Year |
|---|---|
Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Middle Aged; Pain; Pain Management; Pain Measurement; Pregabalin; Psychiatric Status Rating Scales; Research Design; Spain; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2009 |
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Thiophenes; Treatment Outcome | 2011 |
Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.
Topics: Adult; Aged; Analgesics; Antidepressive Agents; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Pilot Projects; Pregabalin; Thiophenes | 2012 |
Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
Topics: Aged; Amitriptyline; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pregabalin; Quality of Life; Sleep; Thiophenes; Treatment Outcome | 2012 |
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Topics: Aged; Analgesics; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Internationality; Male; Middle Aged; Pain; Pregabalin; Thiophenes; Treatment Outcome | 2013 |
Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Topics: Adult; Aged; Amines; Analgesics; Antidepressive Agents; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Management; Pain Measurement; Pregabalin; Treatment Outcome | 2014 |
Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study).
Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Analgesics; Catastrophization; Duloxetine Hydrochloride; Female; Fibromyalgia; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Patient Compliance; Pregabalin; Psychiatric Status Rating Scales; Surveys and Questionnaires; Thiophenes; Treatment Outcome; Young Adult | 2014 |
Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Pregabalin; Treatment Outcome | 2014 |
Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Topics: Aged; Aged, 80 and over; Analgesics; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pregabalin; Severity of Illness Index; Treatment Outcome | 2014 |
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
Topics: Adult; Analgesics; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Middle Aged; Pregabalin; Quality of Life; Quality-Adjusted Life Years; Surveys and Questionnaires; Thiophenes; Time Factors; Treatment Outcome; United States; United States Food and Drug Administration | 2014 |
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Topics: Affect; Age Factors; Aged; Analgesics; Anticonvulsants; Antidepressive Agents; Anxiety; Depression; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Pregabalin; Psychiatric Status Rating Scales; Treatment Outcome | 2016 |
Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Topics: Adult; Aged; Analgesics; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain Management; Pain Measurement; Pregabalin; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2016 |
Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).
Topics: Acceptance and Commitment Therapy; Adult; Analgesics; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pregabalin; Psychotherapy, Group; Spain | 2017 |
Reduced anterior cingulate grey matter volume in painful hand osteoarthritis.
Topics: Aged; Analgesics; Analysis of Variance; Disease Progression; Double-Blind Method; Duloxetine Hydrochloride; Female; Gray Matter; Gyrus Cinguli; Hand Joints; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteoarthritis; Pain Measurement; Pregabalin | 2018 |
Comparison of Preoperative Administration of Pregabalin and Duloxetine on Cognitive Functions and Pain Management After Spinal Surgery: A Randomized, Double-blind, Placebo-controlled Study.
Topics: Adolescent; Adult; Aged; Analgesics; Cognition; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Intervertebral Disc Displacement; Male; Middle Aged; Orthopedic Procedures; Pain Management; Pain Measurement; Pain, Postoperative; Pregabalin; Spine; Treatment Outcome; Young Adult | 2018 |
The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
Topics: Activities of Daily Living; Analgesics; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Duloxetine Hydrochloride; Electric Stimulation Therapy; Female; Humans; Peripheral Nervous System Diseases; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic; Republic of Korea; Time Factors; Treatment Outcome | 2018 |
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Topics: Amitriptyline; Analgesics; Cross-Over Studies; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Pain Management; Pain Measurement; Pregabalin; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; United Kingdom | 2018 |
Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Topics: Adult; Chronic Pain; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Medication Adherence; Middle Aged; Pregabalin; Treatment Outcome; Young Adult | 2019 |
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Topics: Aged; Analgesics, Opioid; Cancer Pain; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Treatment Outcome | 2019 |
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Topics: Adult; Analgesics; Breast Neoplasms; Bridged-Ring Compounds; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Neuralgia; Pregabalin; Surveys and Questionnaires; Taxoids; Treatment Outcome | 2020 |
Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cancer Pain; Duloxetine Hydrochloride; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Prospective Studies; Quality of Life; Treatment Outcome | 2020 |
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Topics: Adult; Aged; Analgesics; Bayes Theorem; Comparative Effectiveness Research; Duloxetine Hydrochloride; Female; Humans; Male; Mexiletine; Middle Aged; Neuralgia; Nortriptyline; Pain Management; Polyneuropathies; Pregabalin; Treatment Outcome | 2021 |
No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial.
Topics: Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pharmaceutical Preparations; Pregabalin; Treatment Outcome | 2022 |
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Topics: Adult; Analgesics, Opioid; Cancer Pain; Clinical Trials, Phase III as Topic; Double-Blind Method; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Neoplasms; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Comparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis.
Topics: Duloxetine Hydrochloride; Humans; Neuralgia; Osteoarthritis, Knee; Pregabalin; Quality of Life; Treatment Outcome | 2022 |
A secondary analysis of PAIN-CONTRoLS: Pain's impact on sleep, fatigue, and activities of daily living.
Topics: Activities of Daily Living; Bayes Theorem; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Fatigue; Humans; Mexiletine; Nortriptyline; Pain; Pregabalin; Prospective Studies; Quality of Life; Sleep; Treatment Outcome | 2022 |
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomise
Topics: Amitriptyline; Analgesics; Cross-Over Studies; Diabetes Mellitus; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Neuralgia; Pregabalin; Treatment Outcome | 2022 |
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Topics: Adult; Amitriptyline; Cost-Benefit Analysis; Diabetes Mellitus; Duloxetine Hydrochloride; Humans; Neuralgia; Pregabalin; Quality of Life | 2022 |
Combination therapy for painful diabetic neuropathy is safe and effective.
Topics: Amitriptyline; Analgesics; Diabetes Mellitus; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Humans; Pregabalin; Treatment Outcome | 2023 |
Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study.
Topics: Acetylcarnitine; Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pregabalin; Treatment Outcome | 2023 |
87 other study(ies) available for duloxetine hydrochloride and pregabalin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2007 |
Career lifetime advances and key developments: diabetes.
Topics: Amines; Amitriptyline; Analgesics; Antidepressive Agents; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Thiophenes | 2007 |
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Clinical Protocols; Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Placebo Effect; Pregabalin; Thiophenes; Treatment Outcome | 2008 |
Duloxetine: an emerging evidence for fibromyalgia.
Topics: Analgesics; Antidepressive Agents; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2009 |
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Clinical Protocols; Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Placebo Effect; Pregabalin; Thiophenes; Treatment Outcome | 2008 |
[Evidence-based recommendations for the treatment of fibromyalgia syndrome].
Topics: Adrenergic Uptake Inhibitors; Analgesics; Antidepressive Agents; Combined Modality Therapy; Consensus Development Conferences as Topic; Cross-Sectional Studies; Duloxetine Hydrochloride; Evidence-Based Medicine; Exercise Therapy; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Practice Guidelines as Topic; Pregabalin; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2010 |
A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
Topics: Amines; Analgesics; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Desipramine; Diabetic Neuropathies; Duloxetine Hydrochloride; Economics, Pharmaceutical; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Pregabalin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Thiophenes | 2008 |
Fibromyalgia coverage uneven despite recent drug approvals.
Topics: Analgesics; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Insurance, Pharmaceutical Services; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sickness Impact Profile; Thiophenes; United States; United States Food and Drug Administration | 2008 |
Successful pain relief of cutaneous leiomyomata due to reed syndrome with the combination treatment of pregabalin and duloxetine.
Topics: Adult; Analgesics, Non-Narcotic; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Leiomyoma; Pain; Pregabalin; Selective Serotonin Reuptake Inhibitors; Skin Neoplasms; Thiophenes | 2009 |
Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Analysis of Variance; Animals; Cyclopropanes; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Electroshock; Formaldehyde; gamma-Aminobutyric Acid; Male; Milnacipran; Pain; Pain Measurement; Pregabalin; Rats; Rats, Sprague-Dawley; Stress, Physiological; Thiophenes; Vocalization, Animal | 2010 |
Pharmacological treatment of fibromyalgia syndrome: new developments.
Topics: Age Factors; Analgesics, Opioid; Calcium Channel Blockers; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Agonists; Duloxetine Hydrochloride; Exercise; Exercise Therapy; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pain; Pain Measurement; Pain Threshold; Pregabalin; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Self Care; Thiophenes; Treatment Outcome | 2010 |
Drugs to treat fibromyalgia - the transatlantic difference.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Cyclopropanes; Drug Approval; Duloxetine Hydrochloride; European Union; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Off-Label Use; Pregabalin; Thiophenes; United States; United States Food and Drug Administration | 2010 |
[Treatment of neuropathies].
Topics: Adjuvants, Immunologic; Adrenergic Uptake Inhibitors; Amines; Analgesics; Antioxidants; Capsaicin; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Polyneuropathies; Pregabalin; Sensory System Agents; Thiamine; Thioctic Acid; Thiophenes | 2010 |
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
Topics: Adult; Amines; Amitriptyline; Analgesics; Antidepressive Agents; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Drug Costs; Duloxetine Hydrochloride; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Humans; Markov Chains; Models, Econometric; Pregabalin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Thiophenes; Tramadol; United Kingdom | 2010 |
Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
Topics: Adolescent; Adult; Age Factors; Analgesics; Comorbidity; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Services; Humans; Insurance Claim Review; Male; Middle Aged; Pain; Pregabalin; Sex Factors; Socioeconomic Factors; Thiophenes; Young Adult | 2010 |
Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
Topics: Adolescent; Adult; Analgesics; Cohort Studies; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Thiophenes; Young Adult | 2011 |
Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
Topics: Adolescent; Adult; Aged; Analgesics; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Care Costs; Humans; Insurance Claim Review; Male; Middle Aged; Pregabalin; Thiophenes; Young Adult | 2012 |
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Thiophenes; Treatment Outcome | 2011 |
Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
Topics: Adolescent; Adult; Aged; Analgesics; Cohort Studies; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Health Services; Humans; Male; Managed Care Programs; Middle Aged; Pregabalin; Thiophenes; United States | 2012 |
Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy.
Topics: Adalimumab; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Psoriasis; Selective Serotonin Reuptake Inhibitors; Thiophenes; Young Adult | 2011 |
Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Algorithms; Analgesics; Comorbidity; Databases, Factual; Dose-Response Relationship, Drug; Drug Costs; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Male; Medication Adherence; Middle Aged; Practice Patterns, Physicians'; Pregabalin; Retrospective Studies; Thiophenes; Young Adult | 2011 |
Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
Topics: Adolescent; Adult; Aged; Analgesics; Comorbidity; Databases, Factual; Drug Therapy; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Expenditures; Humans; Male; Middle Aged; Pregabalin; Retrospective Studies; Thiophenes; United States; Young Adult | 2012 |
Persistent genital arousal disorder: successful treatment with duloxetine and pregabalin in two cases.
Topics: Adult; Anticonvulsants; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Thiophenes; Treatment Outcome | 2012 |
Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.
Topics: Amines; Analgesics; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Dopamine Uptake Inhibitors; Drug Costs; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Mexico; Pregabalin; Thiophenes | 2012 |
Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
Topics: Analgesics; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Pregabalin; Thiophenes | 2012 |
The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Topics: Administration, Oral; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Morphine; Neuralgia; Neuroma; Pain Measurement; Pain Threshold; Pregabalin; Rats; Rats, Sprague-Dawley; Thiophenes; Time Factors | 2012 |
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Drug Interactions; Duloxetine Hydrochloride; Etodolac; gamma-Aminobutyric Acid; Hyperalgesia; Male; Mexiletine; Mice; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Thiophenes; Tissue Distribution | 2012 |
A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
Topics: Analgesics; Antidepressive Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Approval; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Models, Economic; Pregabalin; Quality-Adjusted Life Years; Thiophenes; United States; United States Food and Drug Administration | 2012 |
Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel.
Topics: Duloxetine Hydrochloride; Humans; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Quality of Life; Thiophenes | 2013 |
Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.
Topics: Analgesics; Comorbidity; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Middle Aged; Pregabalin; Rheumatic Diseases; Thiophenes | 2013 |
Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.
Topics: Adolescent; Adult; Cohort Studies; Databases, Factual; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Pregabalin; Retrospective Studies; Thiophenes; Young Adult | 2014 |
Retraumatization eliciting the presentation of fibromyalgia.
Topics: Adult; Analgesics; Antidepressive Agents; Cannabinoids; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pregabalin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Stress, Psychological; Thiophenes; Uterine Rupture | 2013 |
Add-on therapy: when two are not better than one.
Topics: Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Pain; Pregabalin; Thiophenes | 2013 |
Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin.
Topics: Amines; Amitriptyline; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Cyclohexanecarboxylic Acids; Disease Progression; Duloxetine Hydrochloride; Female; Fibromyalgia; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Prescription Drugs; Retrospective Studies; Thiophenes; Treatment Outcome | 2013 |
Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient.
Topics: Adalimumab; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Biological Products; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Psoriasis; Thiophenes; Young Adult | 2013 |
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.
Topics: Aged; Analgesics; Cohort Studies; Databases, Factual; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Middle Aged; Pregabalin; Retrospective Studies; Thiophenes; United States | 2013 |
Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study.
Topics: Aged; Amines; Analgesics; Chi-Square Distribution; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Germany; Health Surveys; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Prospective Studies; Thiophenes; Treatment Outcome | 2014 |
Drugs for neuropathic pain.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pregabalin; Thiophenes; Treatment Outcome | 2013 |
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
Topics: Adult; Analgesics; Cohort Studies; Drug Interactions; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Expenditures; Humans; Male; Middle Aged; Pregabalin; Prevalence; Retrospective Studies; Thiophenes | 2014 |
Painful traumatic trigeminal neuropathy: an open study on the pharmacotherapeutic response to stepped treatment.
Topics: Amines; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Baclofen; Carbamazepine; Clinical Protocols; Cohort Studies; Cyclohexanecarboxylic Acids; Drug Combinations; Duloxetine Hydrochloride; Female; Follow-Up Studies; GABA-B Receptor Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Medical Records; Middle Aged; Nortriptyline; Pain; Pain Measurement; Pregabalin; Prognosis; Prospective Studies; Thiophenes; Treatment Outcome; Trigeminal Nerve Injuries; Trigeminal Neuralgia | 2014 |
Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
Topics: Analgesics; Animals; Cold Temperature; Disease Models, Animal; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Male; Neuralgia; Physical Stimulation; Pregabalin; Rats, Wistar; Sciatic Nerve; Thiophenes; Tramadol | 2014 |
Prior authorization in the treatment of patients with pDPN and FM.
Topics: Adult; Aged; Analgesics; Cohort Studies; Cost of Illness; Cyclopropanes; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Health Services; Humans; Insurance Claim Review; Insurance, Health; Insurance, Pharmaceutical Services; Longitudinal Studies; Male; Middle Aged; Milnacipran; Pregabalin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2015 |
Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
Topics: Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Cohort Studies; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Female; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Health Services; Humans; Male; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Pregabalin | 2015 |
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cohort Studies; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; Male; Medicare Part C; Middle Aged; Pain; Pregabalin; Prescription Drugs; Prevalence; Retrospective Studies; United States; Young Adult | 2015 |
Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Topics: Adult; Aged; Amines; Antidepressive Agents; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pregabalin; Quality of Life; Retrospective Studies; Treatment Outcome; United States | 2015 |
Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
Topics: Administration, Ophthalmic; Analgesics; Animals; Antineoplastic Agents; Axons; Bortezomib; Duloxetine Hydrochloride; Hyperalgesia; Mexiletine; Nerve Degeneration; Neurites; PC12 Cells; Peripheral Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tramadol | 2015 |
Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
Topics: Amines; Analgesics; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Desipramine; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Health Care Costs; Humans; Models, Economic; Pregabalin; Quality-Adjusted Life Years | 2016 |
Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Topics: Analgesics; Cost-Benefit Analysis; Decision Support Techniques; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Pregabalin; Quality of Life; Quality-Adjusted Life Years; Venezuela | 2015 |
Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury.
Topics: Analgesics; Animals; Collagen; Drug Therapy, Combination; Duloxetine Hydrochloride; Male; Neuralgia; Pain Measurement; Peripheral Nerve Injuries; Pharmaceutical Vehicles; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2016 |
[A Case of Severe Peripheral Polyneuropathy Occurring after Entecavir Treatment in a Hepatitis B Patient].
Topics: Administration, Oral; Antiviral Agents; Brain; Drug Therapy, Combination; Duloxetine Hydrochloride; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Male; Middle Aged; Polyneuropathies; Prednisolone; Pregabalin; Tomography, X-Ray Computed | 2016 |
Drug combinations in diabetic neuropathic pain: an experimental validation.
Topics: Amitriptyline; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Male; Neuralgia; Pain Measurement; Pregabalin; Rats; Rats, Wistar; Sitagliptin Phosphate | 2016 |
Efficacy of pregabalin augmentation for refractory pain in late-life depression.
Topics: Aged; Calcium Channel Blockers; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Pain, Intractable; Pregabalin; Psychiatric Status Rating Scales; Tramadol; Treatment Outcome | 2017 |
Changing general medical practices in the management of neuropathic pain
Topics: Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; General Practitioners; Humans; Male; Middle Aged; Neuralgia; Pain Management; Practice Patterns, Physicians'; Pregabalin; Surveys and Questionnaires | 2016 |
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
Topics: Amines; Analgesics; Animals; Anticonvulsants; Antioxidants; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Piracetam; Pregabalin | 2017 |
Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
Topics: Adolescent; Adult; Aged; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Milnacipran; Pregabalin; Retrospective Studies; Venlafaxine Hydrochloride | 2018 |
Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.
Topics: Aged; Aged, 80 and over; Amines; Anesthetics, Local; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Europe; Female; Gabapentin; gamma-Aminobutyric Acid; General Practice; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Treatment Outcome | 2017 |
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
Topics: Administration, Oral; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Fluorouracil; Humans; Imidazoles; Neuralgia; Pregabalin; Pyrroles; Rats; Rats, Sprague-Dawley | 2017 |
Therapeutic effects of diclofenac, pregabalin, and duloxetine on disuse-induced chronic musculoskeletal pain in rats.
Topics: Animals; Chronic Pain; Diclofenac; Disease Models, Animal; Duloxetine Hydrochloride; Humans; Muscle, Skeletal; Muscular Disorders, Atrophic; Musculoskeletal Pain; Pain Measurement; Pain Threshold; Pregabalin; Rats; Rats, Sprague-Dawley | 2018 |
Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Fibromyalgia; Male; Neurotransmitter Agents; Pregabalin; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn | 2018 |
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis.
Topics: Aged; Aged, 80 and over; Analgesics; Clinical Trials as Topic; Double-Blind Method; Duloxetine Hydrochloride; Exercise; Female; Gabapentin; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Treatment Outcome | 2018 |
Risk for Medication Nonadherence Among Medicaid Enrollees With Fibromyalgia: Development of a Validated Risk Prediction Tool.
Topics: Adolescent; Adult; Aged; Cohort Studies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Logistic Models; Male; Medicaid; Medication Adherence; Middle Aged; Pregabalin; Prescription Drugs; Retrospective Studies; Risk Assessment; South Carolina; United States | 2019 |
Change in Pain Score after Administration of Analgesics for Lower Extremity Fracture Pain during Hospitalization.
Topics: Adult; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents; Baclofen; Bones of Lower Extremity; Cohort Studies; Duloxetine Hydrochloride; Female; Fractures, Bone; Gabapentin; Hospitalization; Humans; Male; Middle Aged; Muscle Relaxants, Central; Pain Management; Pain Measurement; Pregabalin; Retrospective Studies | 2019 |
Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.
Topics: Adjuvants, Pharmaceutic; Adult; Analgesics; Analgesics, Opioid; Attitude of Health Personnel; Cancer Pain; Cross-Sectional Studies; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Neuralgia; Palliative Care; Physicians; Pregabalin; Specialization; Surveys and Questionnaires | 2019 |
Distinguishing analgesic drugs from non-analgesic drugs based on brain activation in macaques with oxaliplatin-induced neuropathic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Brain; Cerebral Cortex; Cryopyrin-Associated Periodic Syndromes; Disease Models, Animal; Duloxetine Hydrochloride; Macaca fascicularis; Magnetic Resonance Imaging; Male; Neuralgia; Oxaliplatin; Pregabalin; Somatosensory Cortex; Tramadol | 2019 |
Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pregabalin; Randomized Controlled Trials as Topic; Retrospective Studies; United States | 2020 |
Are there really only 2 kinds of people in the world? Evaluating the distribution of change from baseline in pain clinical trials.
Topics: Analgesics; Clinical Trials as Topic; Duloxetine Hydrochloride; Female; Humans; Male; Pain; Pain Management; Pain Measurement; Pregabalin; Research Design; Treatment Outcome | 2020 |
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Databases, Factual; Duloxetine Hydrochloride; Gabapentin; Humans; Pharmacovigilance; Pregabalin; Risk Factors; Substance-Related Disorders; United States; United States Food and Drug Administration | 2020 |
Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Topics: Adult; Analgesics; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia; Pregabalin; Prospective Studies; Treatment Outcome | 2019 |
Treatment data from the Brazilian fibromyalgia registry (EpiFibro).
Topics: Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Brazil; Cohort Studies; Combined Modality Therapy; Cross-Sectional Studies; Drug Therapy, Combination; Duloxetine Hydrochloride; Exercise; Female; Fibromyalgia; Health Education; Humans; Male; Middle Aged; Muscle Stretching Exercises; Pregabalin; Registries | 2020 |
Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
Topics: Analgesics; Animals; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neuralgia; Osteoarthritis, Knee; Pain Measurement; Pregabalin; Rats, Sprague-Dawley | 2020 |
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
Topics: Analgesics; Animals; Bone and Bones; Cancer Pain; Disease Models, Animal; Duloxetine Hydrochloride; Glycine Plasma Membrane Transport Proteins; Hyperalgesia; Male; Neuralgia; Pain Measurement; Pain Threshold; Pregabalin; Prostatic Neoplasms; Rats; Rats, Wistar | 2020 |
Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
Topics: Adult; Amitriptyline; Antineoplastic Agents; Calcium; Cross-Sectional Studies; Duloxetine Hydrochloride; France; Gabapentin; Humans; Magnesium; Male; Middle Aged; Neurotoxicity Syndromes; Oncologists; Peripheral Nervous System Diseases; Practice Patterns, Physicians'; Pregabalin; Surveys and Questionnaires; Vitamins | 2021 |
Wide-Range Measurement of Thermal Preference-A Novel Method for Detecting Analgesics Reducing Thermally-Evoked Pain in Mice.
Topics: Analgesics; Animals; Antineoplastic Agents; Cold Temperature; Disease Models, Animal; Duloxetine Hydrochloride; Hot Temperature; Hyperalgesia; Male; Mice; Oxaliplatin; Pain; Pain Measurement; Pregabalin; Temperature | 2021 |
Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
Topics: Analgesics; Animals; Benzamides; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Glycine Plasma Membrane Transport Proteins; Hyperalgesia; Indomethacin; Male; Peripheral Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2021 |
Investigation of the Combination of Pregabalin with Duloxetine or Amitriptyline on the Pharmacokinetics and Antiallodynic Effect During Neuropathic Pain in Rats.
Topics: Amitriptyline; Analgesics; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Hyperalgesia; Male; Neuralgia; Pain Measurement; Pregabalin; Rats; Rats, Wistar | 2021 |
Risk of Pregabalin-Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database.
Topics: Aged; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Gabapentin; Humans; Hypoglycemia; Japan; Neuralgia; Pregabalin | 2022 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications.
Topics: Acetaminophen; Adult; Antidepressive Agents; Arrhythmias, Cardiac; Coma; Diazepam; Droperidol; Drug Overdose; Duloxetine Hydrochloride; Female; Humans; Hypotension; Ibuprofen; Middle Aged; Norepinephrine; Oxycodone; Pregabalin; Quetiapine Fumarate; Seizures; Serotonin; Sympathomimetics; Tachycardia | 2022 |
Probable drug-induced clitoral priapism due to potentiating effects of pregabalin and duloxetine.
Topics: Analgesics; Clitoris; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Pregabalin; Priapism; Probability | 2023 |
Botulinum toxin A for management of refractory concurrent buccal and inferior alveolar nerve post-traumatic neuropathies: a case report.
Topics: Amitriptyline; Animals; Botulinum Toxins, Type A; Carbamazepine; Clonazepam; Duloxetine Hydrochloride; Humans; Mandibular Nerve; Neuralgia; Pregabalin; Quality of Life; Venlafaxine Hydrochloride | 2022 |
Response profile in a rat model of exercise-induced hypoalgesia is associated with duloxetine, pregabalin and diclofenac effect on constriction-induced neuropathy.
Topics: Analgesics; Animals; Constriction, Pathologic; Diclofenac; Duloxetine Hydrochloride; Neuralgia; Pain Threshold; Peripheral Nerve Injuries; Pregabalin; Rats | 2023 |
Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study.
Topics: Acetaminophen; Amitriptyline; Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Dipyrone; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Pregabalin; Selective Serotonin Reuptake Inhibitors | 2022 |
Fibromyalgia: Diagnosis and Management.
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Pregabalin | 2023 |
[Medical Treatment of Chronic Pain].
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; Humans; Pregabalin | 2023 |
Amitriptyline, Duloxetine, and Pregabalin Each Effective in Decreasing Pain From Diabetic Peripheral Neuropathy; Combinations Even Better.
Topics: Amitriptyline; Analgesics; Diabetes Mellitus; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Pain; Pregabalin | 2023 |
Chronic Pain Syndromes: Fibromyalgia.
Topics: Chronic Pain; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Milnacipran; Pregabalin | 2023 |